During the development of your diagnostic device, strategic evidence planning can impact future success. We help you to:

• Conduct early reviews to identify unmet needs and disease burden.
• Conduct care pathway analysis to establish the clinical utility and analytical validity of your diagnostic, identifying its precise role within the clinical pathway.
• Develop early models to explore the potential economic value of your diagnostic.
• Conduct gap analysis projects, which involve reviewing the value proposition for a technology and mapping existing evidence against key value messages to inform future evidence generation.
• Structure clinical evidence plans to anticipate future health technology assessment and payer requirements.

YHEC provides support to:

• Integrate the patient voice into evidence development by using outcomes research in a meaningful manner.
• Synthesise your evidence and value story through literature reviews, economic models and statistical analysis.
• Create compelling value communications that are easy to interpret and resonate with stakeholders
• Conduct structured expert elicitation where evidence may be limited, incomplete or uncertain.
• Align your evidence with the expectations of payers, HTA, and other key decision makers.

Preparing your value proposition and market access strategy is important for a successful launch. We work with you to:

• Anticipate payer expectations for economic models and evidence submissions, considering how to demonstrate the impact on downstream costs and patient outcomes.
• Adapt global evidence to local HTA requirements, ensuring your submission is relevant and persuasive for specific national and regional contexts.
• Create defensible HTA submissions that resonate with stakeholders.
• Prepare for HTA consultations and scientific advice meetings.

After launch, continuous monitoring and evidence generation are important for long-term success. We assist you to:

• Strengthen your value proposition with real-world data that reflects the lived experiences of patients and clinicians.
• Prepare for evolving healthcare expectations by embedding considerations of sustainability and equity into your continuous evidence plans.
• Analyse patient registries and health databases to collect real-world data supporting your diagnostic device, leveraging the real-world evidence to enhance your value messages and communications.